Pharmacokinetic interaction of curcumin and glibenclamide in diabetic rats.

about

Pharmacokinetic interaction of curcumin and glibenclamide in diabetic rats.

Item

http://www.wikidata.org/entity/Q36641349

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Pharmacokinetic interaction of curcumin and glibenclamide in diabetic rats.

@ast

Pharmacokinetic interaction of curcumin and glibenclamide in diabetic rats.

@en

type

Item

label

Pharmacokinetic interaction of curcumin and glibenclamide in diabetic rats.

@ast

Pharmacokinetic interaction of curcumin and glibenclamide in diabetic rats.

@en

prefLabel

Pharmacokinetic interaction of curcumin and glibenclamide in diabetic rats.

@ast

Pharmacokinetic interaction of curcumin and glibenclamide in diabetic rats.

@en

P1476

Pharmacokinetic interaction of curcumin and glibenclamide in diabetic rats.

@en

P2093

A Gopala Reddy

http://www.w3.org/2001/XMLSchema#string

C S V Satish Kumar

http://www.w3.org/2001/XMLSchema#string

G Boobalan

http://www.w3.org/2001/XMLSchema#string

G S Rao

http://www.w3.org/2001/XMLSchema#string

P R Sakunthala Devi

http://www.w3.org/2001/XMLSchema#string

P2860

Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

Pharmacokinetic optimisation of oral hypoglycaemic therapy

Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications.

Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms.

Contributions of human cytochrome P450 enzymes to glyburide metabolism.

Herb-drug interactions in nephrology: documented and theoretical.

Sphingolipid signaling reduces basal P-glycoprotein activity in renal proximal tubule.

Therapeutic potential of curcumin in digestive diseases

Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin.

P304

508-511

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14202/VETWORLD.2015.508-511

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275973271

http://www.w3.org/2001/XMLSchema#string

P698

27047124

http://www.w3.org/2001/XMLSchema#string

P921

curcumin

P932

4774801

http://www.w3.org/2001/XMLSchema#string